Live Breaking News & Updates on Hematology Therapeutic Area

Stay updated with breaking news from Hematology therapeutic area. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

J&J: EU green light for Carvykti in multiple myeloma

Janssen-Cilag International NV, a Johnson & Johnson company, announced today that the European Commission has approved a type II variant for Carvykti . This latest approval is for the treatment of. ....

Edmond Chan , Janssen Cilag International , European Commission , Hematology Therapeutic Area , Johnson Innovative ,

CSL and Translational Sciences enter Agreement

CSL and Translational Sciences enter Agreement
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United States , Brahm Goldstein , Translational Sciences , Strategic Option , License Agreement , Arizona Based Translational Sciences , Hematology Therapeutic Area , Sciences Chief Scientific Officer , Guy Reed ,

MIL-OSI Australia: 20221026 CSL enters into Strategic Option and License Agreement with Translational Sciences

MIL-OSI Australia: 20221026 CSL enters into Strategic Option and License Agreement with Translational Sciences
foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.

United States , Brahm Goldstein , Greg Healy , Jimmy Baker , Translational Sciences , Wrd Communications , Strategic Option , License Agreement , Arizona Based Translational Sciences , Hematology Therapeutic Area , Sciences Chief Scientific Officer , Guy Reed ,

Takeda organiza una conferencia telefónica sobre sus productos en desarrollo Wave 1 - Iberonews

Takeda organiza una conferencia telefónica sobre sus productos en desarrollo Wave 1
CAMBRIDGE, Mass. y OSAKA, Japón (BUSINESS WIRE)
Takeda Pharmaceutical Company Limited
(TSE:4502/NYSE:TAK) (“Takeda”) ha anunciado hoy que realizará una conferencia telefónica el 6 de abril de 2021 para informar sobre las nuevas entidades moleculares (NEM) seleccionadas en su cartera de productos en desarrollo Wave 1. Con varias presentaciones de NEM ante las autoridades normativas previstas para fines del ejercicio fiscal 2021, la compañía mencionará sus planes para el crecimiento orgánico y sostenible de los ingresos durante los próximos años.
Texto completo a continuación ....

Sarah Sheikh , Christophe Weber , Ramona Sequeira , Claus Jepsen , Erika Gill , Elena Koundourakis , Panel Qa Session , Orexin Franchise Development , Innovative Pipeline , Select Wave , Potential Game Changer , Post Transplant Cytomegalovirus , Rare Genetic , Hematology Therapeutic Area , Global Product , Launch Strategy , Novel Moa , Dravet Syndrome , Neuroscience Therapeutic Area , Neuroscience Therapeutic , Franchise Strategy Update , First Potential Medicine , Underlying Disease , Narcolepsy Type , Global Portfolio , சாரா ஷேக் ,

Takeda organiza una conferencia telefónica sobre sus productos en desarrollo Wave 1 - Iberonews

Takeda organiza una conferencia telefónica sobre sus productos en desarrollo Wave 1 - Iberonews
iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.

Sarah Sheikh , Christophe Weber , Ramona Sequeira , Claus Jepsen , Erika Gill , Elena Koundourakis , Panel Qa Session , Orexin Franchise Development , Innovative Pipeline , Select Wave , Potential Game Changer , Post Transplant Cytomegalovirus , Rare Genetic , Hematology Therapeutic Area , Global Product , Launch Strategy , Novel Moa , Dravet Syndrome , Neuroscience Therapeutic Area , Neuroscience Therapeutic , Franchise Strategy Update , First Potential Medicine , Underlying Disease , Narcolepsy Type , Global Portfolio , சாரா ஷேக் ,